| Carlos Sanchez, DDS | |
|
710 E San Ysidro Blvd, Suite 1007, San Ysidro, CA 92173-3123 | |
| (619) 870-9456 | |
| (916) 785-3404 |
| Full Name | Carlos Sanchez |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 710 E San Ysidro Blvd, San Ysidro, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578827887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 2394636 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carlos Sanchez, DDS Po Box 426, San Luis, AZ 85349-0426 Ph: (619) 870-9456 | Carlos Sanchez, DDS 710 E San Ysidro Blvd, Suite 1007, San Ysidro, CA 92173-3123 Ph: (619) 870-9456 |
News Archive
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the initiation of dosing in the company's Phase 2 clinical trial of VK5211 in patients who recently suffered a hip fracture.
LifePoint Hospitals, Inc. today announced results for the fourth quarter and year ended December 31, 2012.
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the U.S. Food and Drug Administration has granted marketing approval of the Abbreviated New Drug Application for enoxaparin sodium for injection filed by Sandoz. Developed under a collaboration agreement between Momenta and Sandoz, this product has been designated therapeutically equivalent to the reference-listed drug, Lovenox, which is marketed by Sanofi-Aventis.
Canon Communications today announced the formation of a comprehensive program to assist designers, developers, and engineering managers involved in the design of electronics-based medical devices. The DesignMED conference and exposition is a collaborative project between the company's Medical Device Group-Medical Electronics Design (MED), EDN, and MD+DI-and its Event Division.
› Verified 5 days ago
Dr. Miguel Solorio Jr., Dentist Medicare: Not Enrolled in Medicare Practice Location: 482 W San Ysidro Blvd, #134, San Ysidro, CA 92173 Phone: 619-381-5645 | |
Ana O Contreras-cerrillo, DDS Dentist Medicare: Medicare Enrolled Practice Location: 511 E San Ysidro Blvd, #231, San Ysidro, CA 92173 Phone: 619-606-0372 | |
Natalia Alvarez Maldonado, Dentist Medicare: Medicare Enrolled Practice Location: 157 W Park Ave, San Ysidro, CA 92173 Phone: 619-513-4077 | |
Dr. Max Corona, Dentist Medicare: Not Enrolled in Medicare Practice Location: 482 W San Ysidro Blvd, Suite 1268, San Ysidro, CA 92173 Phone: 760-208-4986 | |
Dr. Guillermo Shiroma, DDS Dentist Medicare: Medicare Enrolled Practice Location: 4004 Beyer Blvd, San Ysidro, CA 92173 Phone: 619-428-4463 Fax: 619-428-2625 | |
Dr. Mario M. Durazo, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 482 W San Ysidro Blvd, Suite 1944, San Ysidro, CA 92173 Phone: 619-781-9961 | |
Yadira L Gamez, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2004 Dairy Mart Rd, Ste 120, San Ysidro, CA 92173 Phone: 619-428-2436 Fax: 619-428-2447 |